Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, October 19, 2020
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
[ Mon, Oct 19th 2020
] - WOPRAI
John Newman Maintained (AGIO) at Strong Buy with Decreased Target to $70 on, Oct 19th, 2020
John Newman of Canaccord Genuity, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Strong Buy with Decreased Target from $72 to $70 on, Oct 19th, 2020.
John has made no other calls on AGIO in the last 4 months.
There is 1 other peer that has a rating on AGIO. Out of the 1 peers that are also analyzing AGIO, 0 agree with John's Rating of Hold.
This is the rating of the analyst that currently disagrees with John
- Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $72 on, Friday, July 31st, 2020
